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Abstract: This study investigated the possibility of simultaneously extracting glucose and 
lactate from human subjects, at the same skin location, using transdermal reverse iontophoresis. 
Transdermal monitoring using iontophoresis is made possible by the skin’s permeability to small 
molecules and the nanoporous and microporous nature of the structure of skin. The study was 
intended to provide information which could be used to develop a full, biosensor-based, monitoring 
system for multiple parameters from transdermal extraction. As a precursor to the human study, 
in vitro reverse iontophoresis experiments were performed in an artiﬁ  cial skin system to establish 
the optimum current waveforms to be applied during iontophoresis. In the human study, a bipolar 
DC current waveform (with reversal of the electrode current direction every 15 minutes) was 
applied to ten healthy volunteers via skin electrodes and utilized for simultaneous glucose and 
lactate transdermal extraction at an applied current density of 300 µA/cm2. Glucose and lactate 
were successfully extracted through each subject’s skin into the conducting gel that formed part 
of each iontophoresis electrode. The results suggest that it will be possible to noninvasively and 
simultaneously monitor glucose and lactate levels in patients using this approach and this could 
have future applications in diagnostic monitoring for a variety of medical conditions.
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Introduction
Epidemiological studies have shown that the prevalence of diabetes is steadily 
increasing and is a widespread problem in modern society (King et al 1993; Amos et al 
1997; Wild et al 2004). The number of cases of diabetes worldwide in 2000 among 
adults 20 years of age was estimated to be 171 million (Wild et al 2004) and in 2003 
this was estimated to be 194 million (IDF 2003). By 2025, the number of people with 
diabetes is expected to exceed 333 million .
Diabetes increases the risk of ill health and shortens life. It is the leading cause 
of blindness and visual impairment (Evans 1995), amputation (Davis et al 2004), 
cardiovascular disease (Laing et al 1999a, 1999b), stroke (Bell 1994; Stephenson et al 
1995) and kidney failure (Wang et al 1996; Brancati et al 1997).
Tight monitoring and control of blood glucose levels can reduce the prevalence 
of complications in both Type 1 and Type 2 diabetes (UK Prospective Diabetes Study 
Group, 1998a,1998b, 1998c, 1998d). To date, most Type 1 and Type 2 diabetic patients 
measure their own blood glucose several times a day by obtaining ﬁ  nger-prick capil-
lary samples and applying the blood to a reagent strip for analysis in a portable meter 
(Pickup 2003). However, this method is painful, cumbersome, aesthetically unpleas-
ant and inconvenient and blood glucose monitoring cannot continue during sleep. 
This provides considerable impetus for the development of noninvasive methods for 
continuous blood glucose monitoring.International Journal of Nanomedicine 2008:3(2) 212
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Skin provides a unique gateway for noninvasive, 
transdermal monitoring. Recently, reverse iontophoresis 
techniques have been used for patient monitoring (Rao et al 
1995; Tamada et al 1999; Pitzer et al 2001; Tierney et al 2001; 
Potts et al 2002; Degim et al 2003) and noninvasive diagnosis 
(Numajiri et al 1993; Mize et al 1997; Merino et al 1999), 
most notably the GlucoWatch® biographer which proposed 
a solution for diabetics which avoided the frequent need for 
blood sampling (Tamada et al 1999). Reverse iontophoresis 
refers to the passage of a low level of current through the skin, 
normally via a pair of skin electrodes containing a conducting 
gel, to promote the extraction of both charged and neutral 
molecules. The major mechanisms for transport of ions and 
molecules are; the electromigration of charged species to 
the electrode of opposite polarity, electroosmosis of neutral 
molecules to the cathode or anode, or a combination of these 
two processes. The most successful reverse iontophoresis 
application for patient monitoring to date, as mentioned, 
has been in noninvasive and continuous blood glucose 
detection utilising the GlucoWatch®. The GlucoWatch® 
biographer utilized the techniques of reverse iontophoresis 
and biosensing to noninvasively and continuously monitor 
blood glucose. However, the GlucoWatch® had some 
problems, for example it was reported that it does not reliably 
detect hypoglycemia in children (The Diabetes Research 
in Children Network 2004). In addition there have been no 
further developments of commercial systems to monitor any 
other blood analytes transdermally. Consequently there is 
room for further study, understanding and development of 
transdermal reverse iontophoresis for noninvasive patient 
monitoring.
The present study investigated the possibility that other 
blood parameters could be monitored simultaneously with 
glucose through the skin utilizing a single device on a 
patient. Lactate was selected as a parameter of interest for 
a variety of clinical conditions. Glucose and lactate levels 
are metabolically linked and therefore are indicative of the 
healthy functioning of an organism or tissue section when 
monitored simultaneously
Monitoring of lactate is known to be beneﬁ  cial to the 
critical care patient as the trend in lactate levels is an indica-
tor of patient viability (Abramson et al 1993). Blood lactate 
levels have been widely used for prognosis of critical illness 
and assessing effects of therapeutic maneuvers (Cairns et al 
1997; Vincent 1998; Mooney et al 1999). Blood lactate is 
an extremely fast indicator of oxygen deprivation at the cel-
lular level, increasing within seconds of a life threatening 
event and decreasing within seconds of appropriate therapy 
(Bakker et al 1991). Blood lactate has also been reported to 
be superior to other variables (eg, oxygen-derived variables) 
as a predictor of outcome (Mooney et al 1999). In critical 
care units, high lactate levels in the general circulation 
have a strong prognostic value (Vincent 1996), with lac-
tate levels over 5 mM (normally 0.6–2.4 mM) associated 
with a poor outcome. Therefore, it is possible to predict 
organ failure from serial lactate measurements (Gersh and 
Anderson 1993). Lactate monitoring has been suggested 
as valuable for many patients in emergency medicine: for 
surgical patients (Elia et al 1991; Hildingsson et al 1996; 
Carrier et al 1998; Habicht et al 1998), for trauma patients 
(Slomovitz 1998), for patients with head injury or cerebral 
ischemia (Valadka 1998; Menzel et al 1999), acute intestinal 
ischemia (Murray et al 1994), liver ischemia (Rasmussen 
et al 1994), transplanted organ surveillance eg, myocutane-
ous ﬂ  aps (Rojdmark et al 1998), intrapartum for the fetus 
(Westgren et al 1999), and patients with septic shock (Boer 
et al 1994).
Clinically, a patient’s blood lactate level can be tracked 
in a minimally-invasive manner by microdialysis (Volpe et al 
1994) or through ﬁ  nger-stick sampling. Although the micro-
dialysis sampling method, when combined with a biosensor 
or other analysis technique, can provide continuous lactate 
monitoring it still has a chance of inducing infection on the 
insertion site and surgical intervention is required for this 
technique. The microdialysis tubing generally needs replace-
ment after a 48 hour period. On the other hand, the ﬁ  nger-stick 
method cannot provide continuous lactate monitoring.
The ability to monitor both glucose and lactate simulta-
neously and noninvasively would have applications in many 
of the clinical conditions described above. In addition this 
measurement technique could be applied to monitor the 
viability of skin grafts post operatively and to assess the 
vascular condition of skin and limbs.
The use of reverse iontophoresis in patient monitoring 
does present some concerns. For example, use of constant 
direct current (DC) during transdermal reverse iontophoresis 
may localise and generate hydroxyl ions in the anodal skin 
region and hydrogen ions in the cathodal skin region. This 
process, which disrupts local pH values, leads to stinging 
and erythrema (Howard et al 1995). The use of pulsed DC, 
(a constant DC delivered periodically), has been suggested 
to prevent charge build up on the skin (polarization) and 
minimize pH changes (Chien et al 1987; Chien et al 1990). 
Polarization effects turn the skin into what is effectively 
a charged capacitor and this reduces the ﬂ  ow of current 
and charged species during iontophoresis. When current is International Journal of Nanomedicine 2008:3(2) 213
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switched off the skin naturally depolarizes and returns to its 
near initial electrical condition. The use of bipolar current, a 
constant DC source where direction of current ﬂ  ow through 
the skin electrodes is changed periodically, has also been 
suggested as a means to overcome skin polarisation and 
minimize pH changes (Howard et al 1995; Tomohira et al 
1997). Tomohira and colleagues (1997) used an in vivo 
rat abdominal skin model to study the effect of electrode 
polarity switching (ie, a bipolar DC current proﬁ  le with the 
polarity of the electrodes switched over at speciﬁ  c intervals) 
in the iontophoresis of insulin and calcitonin for transdermal 
delivery. They found that applied bipolar DC current proﬁ  les 
could enhance the absorption of the insulin and calcitonin. 
Hirvonen and colleagues (1995) used a diffusion cell with 
mouse skin to study the impact of different applied current 
proﬁ  les (waveforms) in regulating the permeation of two 
charged amino acids, lysine and glutamic acid. They found 
that bipolar current waveforms or constant DC current 
waveforms resulted in comparable transport rates which 
are both higher than that of pulsed DC current waveforms. 
Bipolar current waveforms were selected for investigation 
in this study.
The aims of this study were; (1) to establish the optimum 
applied current waveforms for the transdermal reverse ion-
tophoresis of both glucose and lactate and (2) to study the 
simultaneous reverse iontophoretic extraction of glucose 
and lactate across human skin barriers in healthy human 
subjects.
The effects of applied current waveforms on the reverse 
iontophoresis of glucose and lactate were initially investigated 
using in vitro diffusion cells designed to mimic human skin 
conditions. These were utilized with an artiﬁ  cial membrane 
as a skin substitute, avoiding the sample to sample varia-
tion found in human skin whilst allowing the study of how 
the electrical waveform affects the transport of glucose and 
lactate (Connolly et al 2002). The optimum applied current 
waveform found from these experiments was then applied 
to healthy human volunteers, and glucose and lactate were 
extracted simultaneously from the subjects’ skin using a 
specially-designed collection electrode.
Materials and methods
Constant current source
A fully programmable, portable constant current source, 
designed and developed by the authors for iontophoresis 
applications (Ching et al 2005), was used to deliver iontopho-
retic current for both in vitro and human reverse iontophoresis 
experiments. The device is capable of delivering constant 
DC current, bipolar DC current waveforms and DC current 
pulses according to how it is programmed.
In vitro reverse iontophoresis experiments
A HEPES buffer solution was used for in vitro experi-
ments. N-2-hydroxyethylpiperazine-N’-2-ethanesulphonic 
acid (HEPES), sodium chloride (NaCl), sodium hydroxide 
(NaOH), hydrochloric acid (HCl) and lactate were purchased 
from Sigma Chemical Co. (St. Louis, MO). Glucose was 
purchased from BDH Limited (Poole, England). Lactate 
reagents (LC 2389) and glucose reagents (GL 26233) were 
purchased from Randox Laboratories Limited (Antrim, UK). 
De-ionized water (resistivity 18M Ωcm) that had been puri-
ﬁ  ed by a Millipore System (Milli-Q UFplus; Bedford, MA) 
was used to prepare all solutions. Nanoporous membrane 
with a net negative charge at pH 7 was used as the artiﬁ  cial 
skin model (Spectra/Por® cellulose ester dialysis membrane 
MWCO: 500, Spectrum Laboratories, Inc., Canada) in 
accordance with earlier studies of the iontophoresis model 
(Connolly et al 2002).
Silver-silver chloride (Ag/AgCl) electrodes were prepared 
by chloriding silver wire (1mm diameter, 25 mm length, 
99.99% pure; Aldrich Chemical Company Inc., Milwaukee, 
WI) immersed in 0.1M HCl solution (Pt-cathode) for 90 
minutes at an applied current of 314 µA.
All in vitro experiments were performed using model 
diffusion cells designed for iontophoresis experiments 
(Connolly et al 2002), in which both electrode cham-
bers were located on the same surface side of a nanoporous 
membrane as shown in Figure 1. The electrode chambers 
were ﬁ  lled with 350 µl of 25 mM, pH 7.4, HEPES buffer 
containing 133 mM NaCl. The lower chamber of the dif-
fusion cell contained an electrolyte solution comprising 
133 mM NaCl, buffered to pH 7.4 with 25 mM HEPES, 
and either 5 mM glucose or 10 mM lactate. Each electrode 
chamber contained a Ag/AgCl electrode. The surface area 
of the nanoporous membrane exposed to the electrode in 
each chamber was 0.2 cm2 and the electrode chambers 
were 11 mm apart. The device was operated at ambient 
temperature (21–23 °C).
An iontophoretic current of 0.3 mA/cm2 was used for 
the various applied current waveforms tested in vitro in the 
cells and each experimental current condition was sustained 
for 60 minutes with current supplied through the Ag/AgCl 
wire electrodes.
The applied current waveforms tested in this study were: 
(i) constant DC current for the entire duration of current 
ﬂ  ow, (ii) DC current with the polarity of the electrode pair International Journal of Nanomedicine 2008:3(2) 214
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reversed every 5 minutes during the 60 minutes of the current 
ﬂ  ow, (iii) DC current with the polarity of the electrode pair 
reversed every 10 minutes during the 60 minutes of the 
current ﬂ  ow, (iv) DC current with the polarity of the elec-
trode pair reversed every 15 minutes during the 60 minutes 
of the current ﬂ  ow.
Each applied current waveform was tested in the model 
iontophoresis cell and the entire contents of the electrode 
chambers were removed at the end of each experimental 
procedure and analyzed to quantify the amount of glucose 
or lactate extracted through the nanoporous membrane. For 
the control experiments, all the experimental arrangements 
and procedures were the same as those described for the 
reverse iontophoresis experiments except that no current 
was applied in the control experiments, allowing diffusion 
of lactate and glucose through the nanoporous membrane to 
be observed in the collection chambers.
A colorimetric clinical chemistry assay method, was 
adapted for use with a microplate reader (Multiskan Ascent®, 
Labsystems Oy, Finland), and was used to quantify the 
amount of glucose (determined by Glucose reagents, GL 
26233, Randox Laboratories Limited, UK) or lactate (deter-
mined by Lactate reagents, LC 2389, Randox Laboratories 
Limited, UK) extracted through the nanoporous membrane. 
For the test, 150 µl of each extracted sample was mixed with 
150 µl of the corresponding Glucose/Lactate reagents and 
dispensed as a sample into a 96-well microplate (Multiskan 
Ascent, Labsystems Oy, Finland). When loaded with samples 
the microplate was then immediately placed on the microplate 
reader. Each plate was incubated for 90 minutes at 37 °C in 
the microplate reader and absorbance read at either 500 nm 
(for glucose) or 550 nm (for lactate). Excellent linear rela-
tionships (r2  0.99 for both cases) between lactate/glucose 
standard solutions and their relative absorbance were found 
in the calibration curves for these assays, allowing the lactate/
glucose concentrations from the model cells to be calculated 
by linear regression.
Human reverse iontophoresis 
experiments
Sodium phosphate monobasic (USP grade) and NaOH were 
purchased from Sigma-Aldrich. Methylcellulose (MC), 
Methocel A4M Prem, from the Dow Chemical Company 
was used to form the electrode contact gels. 0.1 M phosphate 
buffer solution (PBS) was prepared by dissolving 1.1998 g of 
sodium phosphate monobasic in 100 ml de-ionized water and 
adjusting the pH to 7.4 using a 40% w/v solution of NaOH. 
A 4% w/v MC gel was prepared by mixing 4g of MC with 
100 ml of 0.1M PBS. De-ionized water (resistivity 18M 
Ωcm) that had been puriﬁ  ed by a Millipore System (Milli-Q 
UFplus; Bedford, MA) was used to prepare all solutions.
Circular (11.3 mm diameter) screen-printed Ag/AgCl 
electrodes (SPE) were fabricated by printing ink through a 
screen pattern to a thin polyvinyl chloride sheet. Silver paste 
and Silver-silver chloride (Ag/AgCl) paste for printing the 
electrodes was purchased from Advanced Conductive Materials 
(Atascadero, CA). Each SPE was coated with 90 µl of the MC 
(4%) gel described above within a silicone ring. The MC (4%) 
gel acts as a conductive media for the transmission of iontopho-
retic current from the SPE to the human skin and also acts as 
Constant Current Source
+ -
25mM HEPES buffer 
(133mM NaCl, pH 7.4) 
Electrode
chamber
Ag/AgCl electrode
Nanoporous
membrane
Either 5mM glucose or 
10mM lactate in 25mM
HEPES buffer (133mM
NaCl,p H 7.4) .
Stirrer
Lower
chamber
Figure 1 Schematic illustration of the model diffusion cell for in vitro reverse iontophoresis experiments. For the control experiment, the experimental setting was identical 
except no current ﬂ  owed through the Ag/AgCl electrodes.International Journal of Nanomedicine 2008:3(2) 215
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a collector of the extracted lactate and glucose. The prepared 
electrodes were used in pairs on the human subjects. A prepared 
electrode ready for human use is shown in Figure 2.
Ten healthy human volunteers (8 men and 2 women), aged 
between 22 and 35 years (mean = 26.8, SD = 3.7), with no his-
tory of dermatological disease participated in this study. The 
subjects were required to maintain the forearm sites under 
investigation free from application of any cosmetic topical 
formulations for at least 5 days before the study. The subjects 
were not fasted before the study and the measurements were 
taken during the working day. The study was approved by the 
University of Strathclyde Ethics Committee and informed 
consent was obtained from each volunteer.
The areas of skin of each subject’s inner forearm where 
SPEs were to be located were prepared by briskly rubbing 
the areas for 6–8 seconds with alcohol soaked pads to remove 
dry skin, oils and other contaminants. The skin was then 
allowed to dry thoroughly. Then, four SPEs were positioned 
on the subject’s inner forearms and ﬁ  xed in position with 
surgical tapes. Each pair of SPEs was set with about 23 mm 
between the electrode centres and the two pairs of SPEs were 
kept about 50 mm apart. An iontophoretic applied current 
waveform with a current density of 0.3 mA/cm2, and polarity 
reversal of the electrodes every 15 minutes during current 
ﬂ  ow, was applied on one pair of the SPEs on each volunteer’s 
skin for a period of 60 minutes. The second pair of SPEs 
was used as a simultaneous control with no current passing 
through it. At the end of the experiment, the gel sampled from 
each of the paired SPEs (2 controls and 2 current sources) 
was mixed thoroughly as it was sampled and 20 µl samples 
of the MC gel were carefully pipetted from each SPE and 
stored separately in microcentrifuge tubes at 4 °C for later 
quantiﬁ  cation of lactate and glucose. The subject’s blood 
glucose and lactate level was also measured before and after 
experiments by a portable glucose meter (FreeStyle Blood 
Glucose Monitoring System, TheraSense Ltd., UK) and a 
portable lactate meter (Accutrend® Lactate, Roche Diagnos-
tics GmbH, Germany), respectively.
For the analysis of the samples 180 µl of 0.1M PBS was 
pipetted to each microcentrifuge tube containing the extracted 
20 µl MC gel. The solutions were then mixed well. These 
solutions were then subjected to the colorimetric assays 
described before to determine the concentration of lactate 
and glucose in each gel sample.
Results
In vitro studies
In vitro diffusion studies were performed using the nanopo-
rous membrane as the skin-like barrier in the iontophoresis 
cell with and without application of iontophoretic current. 
It was shown that passage of a current facilitates movement 
of lactate and glucose across the nanoporous membrane 
when compared to ordinary diffusion. The applied electri-
cal current waveforms for reverse iontophoresis of lactate 
and glucose were (i) DC only and (ii) DC with an electrode 
polarity reversal every 5, 10 or 15 minutes, respectively. The 
results for glucose and lactate in vitro extraction are shown 
in Figure 3.
In the in vitro lactate diffusion studies, it was found that 
there is a signiﬁ  cant difference between the four applied 
(a) (b)
Silver-silver chloride
Pad
Silver Conducting 
Track
Methylcellulose gel (4%) 
on top of the Ag/AgCl Pad 
Figure 2 The screen-printed electrodes. (a) The front view, with methylcellulose gel (4%) pipetted to this side. (b) The back view, with circular window for crocodile clip 
connection.International Journal of Nanomedicine 2008:3(2) 216
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current waveforms (one-way ANOVA: p  0.001). Lactate 
extraction at the anode during continuous current passage 
(without a polarity reversal) was, as might be expected for 
a negatively charged ion, found to be signiﬁ  cantly higher 
than that at all other applied current waveforms (LSD post-
hoc multiple comparisons: p  0.001 in all cases), except 
the 15 minute electrode polarity reversal waveform. Lactate 
extraction using the 15 minute electrode polarity reversal 
condition was found to be signiﬁ  cantly higher (LSD post-hoc 
multiple comparisons: p  0.001 in both cases) than that of 
protocols utilizing 5 and 10 minutes electrode polarity rever-
sal conditions. It was also found that there was a signiﬁ  cant 
higher lactate extraction for 5, 10 and 15 minutes electrode 
polarity reversal protocols than that in the control sample 
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Figure 3 In vitro reverse iontophoresis extraction of (a) lactate and (b) glucose (mean ± SD; n  12 for each bar), as a function of applied current waveforms. The iontopho-
retic current and current application time are 0.3 mA/cm2 and 60 minutes, respectively. The electrolyte in the electrode chambers of the diffusion cell was 25 mM, pH 7.4, 
HEPES buffer containing 133 mM NaCl. The lower chamber of the diffusion cell were ﬁ  lled with an electrolyte solution comprising 133 mM NaCl, buffered to pH 7.4 with 25 
mM HEPES, and either10 mM lactate or 5 mM glucose.International Journal of Nanomedicine 2008:3(2) 217
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which utilized diffusion-only extraction (LSD post-hoc 
multiple comparisons: p  0.05 in all cases).
In the in vitro glucose diffusion studies, a signiﬁ  cant 
difference was found between the four applied current 
waveforms (one-way ANOVA: p  0.001). It was found that 
glucose extraction at 15 minute electrode polarity reversal 
was signiﬁ  cantly higher than that at all other applied current 
waveforms (LSD post-hoc multiple comparisons: p  0.001 
in all cases). A signiﬁ  cantly higher glucose extraction was 
also found in 5, 10 and 15 minutes electrode polarity rever-
sal than the control (LSD post-hoc multiple comparisons: 
p  0.001 in all cases). It can be seen in Figure 3 that anodal 
extraction of glucose was greater than cathodal extraction but 
it was not a signiﬁ  cant difference.
Transdermal extraction of glucose 
and lactate from human subjects
During the human studies, lactate and glucose were success-
fully extracted simultaneously from the subjects’ skin using 
reverse iontophoresis.
Only one subject (Subject D) reported any discomfort, 
mainly the experience of a very weak tingling sensation as the 
current was brought to 0.3 mA at the start of the experiment 
and when the electrode polarity reversed. At time zero (the 
start of current ﬂ  ow), she experienced a tingling sensation 
which lasted no longer than two seconds. At time = 15 min-
utes of current passage (ie, the moment of electrode polarity 
reversal), she again experienced a tingling sensation which 
also lasted no longer than two seconds. After that, she did not 
experience any other further discomfort or sensations. Four 
subjects had very mild erythema at the reverse iontophoresis 
site after the experiment and this lasted for 15–30 minutes 
after termination of current ﬂ  ow.
The results of analysis of the human studies are summa-
rized in Tables 1 and 2 and Figures 4, 5 and 6. Transdermal 
diffusion of both lactate and glucose occurred for each 
subject, as observed in the control electrodes that were not 
subjected to iontophoretic current. However, reverse ionto-
phoresis was found to signiﬁ  cantly promote more glucose 
extraction (around 4 times greater) and lactate extraction 
(around 2.5 times greater) than diffusion alone (independent 
t-test: p  0.001 in both cases) as shown in Figure 4.
The blood glucose levels of the ten healthy volunteers at 
the start of the experiment and the extracted glucose levels 
(averaged glucose found in both gel electrodes) after reverse 
iontophoresis were compared (see Figure 5) and poor correla-
tion was found between extracted and blood glucose across 
the subject group (r2 = 0.44). It was found that there was no 
signiﬁ  cant different in the volunteers’ blood glucose levels 
before and after experiment (paired t-test: p = 0.227). The 
poor correlation across the group when comparing internal 
versus extracted glucose is due to skin permeability differ-
ences between human subjects and an individual calibration 
of the device for each subject would be required for practical, 
time dependent monitoring.
Similarly, the blood lactate levels of the ten healthy vol-
unteers at the start of the experiment and the extracted lactate 
levels (averaged lactate extraction across both electrodes) 
were also compared (see Figure 6) and no correlation was 
found (r2 = 0.19). It was found that there was no signiﬁ  cant 
different on the volunteers’ blood lactate level before and 
after experiment (paired t-test: p = 0.116). Again, the lack 
Table 1 Measured blood lactate level and transdermally extracted lactate level for the 10 healthy volunteers
Real blood lactate level (mmol/L) Extracted lactate level (µM)
Before 
experiment
After
experiment
Reverse iontophoresis group Control group
Electrode 1 Electrode 2 Mean SD Electrode 1 Electrode 2 Mean SD
Subject A 1.8 1.1 426.9 350.2 388.5 54.2 109.2 107.1 108.2 1.5
Subject B 1.6 1.3 374.9 360.0 367.5 10.5 123.5 115.0 119.2 6.0
Subject C 2.2 1.7 311.5 315.7 313.6 3.0 181.8 132.9 157.4 34.6
Subject D 1.0 1.2 361.7 238.1 299.9 87.4 182.7 116.6 149.6 46.8
Subject E 2.4 1.8 377.5 460.6 419.0 58.7 128.2 128.2 128.2 0.0
Subject F 1.4 1.9 347.9 369.2 358.5 15.1 128.7 122.3 125.5 4.5
Subject G 1.9 1.5 372.8 285.7 329.2 61.6 151.7 200.6 176.2 34.6
Subject H 1.5 1.6 415.1 344.7 379.9 49.8 180.5 140.0 160.2 28.6
Subject I 1.6 1.5 408.0 295.0 351.5 79.9 158.5 149.9 154.2 6.1
Subject J 1.5 1.2 365.7 312.6 339.2 37.5 108.9 104.6 106.8 3.0
Mean 1.7 1.5 376.2 333.2 145.4 131.7
SD 0.4 0.3 34.0 59.8 29.5 28.1International Journal of Nanomedicine 2008:3(2) 218
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of correlation across the group in internal versus extracted 
lactate is most likely to be due to skin permeability differ-
ences between human subjects and individual calibration of 
the device for each subject would be required for any practical 
application of the technique.
Discussion and conclusions
For the in vitro diffusion studies, cellulose ester nanoporous 
membrane was used to substitute for human or animal skin 
samples in order to avoid the large sample-to-sample differ-
ences in human skin. This allowed the electrical properties 
of the electrodes and the effects of the electrical waveforms 
on reverse iontophoresis of lactate and glucose to be studied 
without the nonuniformities introduced by large sample-to-
sample variation in animal tissue. Moreover, the availability 
of excised human or animal skin samples is becoming limited 
for legal, ethical and safety reasons. Though excised human 
skin samples can be obtained, they may have a wide range 
of physical parameters that differ and therefore introduce a 
signiﬁ  cant scatter into any skin transport experiments. Thus 
basic electrical characterisation studies of the electrodes and 
instrumentation for iontophoresis are preferably conducted in 
as controlled an environment as possible before skin studies 
commence.
In the in vitro glucose diffusion studies, glucose is an 
uncharged molecule and therefore electroosmosis is the 
main mechanism for glucose extraction during reverse 
iontophoresis. Because the efﬁ  ciency of electroosmotic 
ﬂ  ow is weakly dependent upon current density in the range 
of 0.14–0.55 mA/cm2 (Delgado-Charro and Guy 1994), a 
current density for iontophoresis of 0.3 mA/cm2, close to 
the value recommended as an upper limit by other workers 
(Ledger 1992), was used.
Electroosmotic ﬂ  ow is always in the same direction as 
the ﬂ  ow of counter ions. Since human skin is negatively 
charged under physiological conditions (Burnette 1987), the 
counter ions are cations and the electroosmotic ﬂ  ow is thus 
from anode to cathode (Guy et al 2000; Pikal 2001). The 
nanoporous membrane used in the diffusion cell is nega-
tively charged. Therefore, electroosmotic ﬂ  ow in this model 
system should be from anode to cathode during direct cur-
rent reverse iontophoresis and thus more glucose should be 
found at cathode rather than anode. However, in this model 
system, extracted level of glucose at the anode was slightly 
greater than that found at the cathode during direct current 
reverse iontophoresis but this was not signiﬁ  cant. This result 
was not in agreement with other researchers (Rao et al 1993, 
1995). The reason that the anodal extraction is greater than 
the cathodal extraction may be due to neutral or positively 
charged pores existing in the membrane (Pikal and Shah 
1990). It is also possible that some masking of negative 
charge in the nanoporous membrane or some membrane 
polarization occurred which reduced the effect of cathodal 
electroosmosis.
As can be seen in Figure 3b, the amount of glucose 
extracted in the model system at either 10 or 15 minutes 
switching time was signiﬁ  cantly more than that obtained by 
continuous current passage without switching of the elec-
trode polarity (ie, cathode and anode held constant) but this 
was inconsistent with the results reported by Santi and Guy 
(1996). They found that total mannitol extractions were sta-
tistically equivalent for the continuous current passage with 
Table 2  Measured blood glucose level and transdermally extracted glucose level for the 10 healthy volunteers
Real blood glucose level 
(mmol/L)
Extracted glucose level (µM)
Before 
experiment
After 
experiment
Reverse iontophoresis group Control group
Electrode 1 Electrode 2 Mean SD Electrode 1 Electrode 2 Mean SD
Subject A 4.6 4.4 117.1 140.8 128.9 16.7 30.2 30.2 30.2 0.0
Subject B 4.8 5.7 181.6 96.1 138.8 60.5 41.6 26.1 33.8 11.0
Subject C 4.6 4.6 202.5 194.4 198.5 5.7 57.6 25.4 41.5 22.8
Subject D 4.3 4.9 161.9 138.2 150.1 16.8 67.0 27.4 47.2 28.0
Subject E 5.3 4.6 222.7 222.7 222.7 0.0 25.3 25.3 25.3 0.0
Subject F 5.1 5.6 148.0 163.7 155.9 11.1 45.9 14.5 30.2 22.2
Subject G 4.6 4.7 151.7 151.7 151.7 0.0 70.9 22.4 46.6 34.3
Subject H 4.6 4.4 149.9 174.4 162.2 17.3 43.8 60.1 51.9 11.5
Subject I 4.2 5.6 115.4 74.3 94.9 29.1 25.0 25.0 25.0 0.0
Subject J 4.7 4.8 152.9 145.3 149.1 5.4 30.7 53.6 42.1 16.2
Mean  4.7 4.9 160.4 150.2 43.8 31.0
SD 0.3 0.5 34.0 43.4 16.7 14.3International Journal of Nanomedicine 2008:3(2) 219
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or without switching, albeit that a different sugar molecule 
was studied. The increased glucose extracted in this study 
with electrode polarity reversal may be due to effective depo-
larization of the membrane (Banga and Chien 1988).
Based on the ﬁ  ndings, it is postulated that a 15 minute 
time interval for electrode polarity reversal is optimum in an 
applied current waveform as it extracts signiﬁ  cantly more glu-
cose than found in the control gel (at least 3.9 times greater) 
and more than DC current passage alone (at least 3.1 times 
greater) within the present study.
In the in vitro lactate diffusion studies, results showed that 
reverse iontophoresis could facilitate lactate extraction and 
applied current waveforms governed the amount of lactate 
to be extracted. Lactate, a negatively charged ion, is mainly 
extracted by electromigration during reverse iontophoresis. 
Based on a general principle of electricity, with like charges 
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Figure 4  Average results of long duration bipolar direct current application (current density of 0.3 mA/cm2, polarity of electrodes reversed at intervals of 15 minutes, 
experimental time of 60 minutes) on human transdermal extraction of (a) lactate and (b) glucose (mean ± SD; n = 10 ). Extraction of lactate or glucose by reverse ionto-
phoresis was signiﬁ  cantly higher (p < 0.001 for both cases) than that of the control sample.International Journal of Nanomedicine 2008:3(2) 220
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repelling each other and opposite charges attracting each 
other, lactate passed easily across the nanoporous membrane to 
the anode during continuous current passage. Therefore, more 
lactate should be detected at the anode than at the cathode.
Clearly, the time of the application of positive polarity 
to the electrode in any chamber during periodic electrode 
polarity reversal is half of that of the continuous current 
conditions. However, the lactate found in either chamber 
in the polarity reversal mode tended to be a function of the 
overall positive and negative current cycles in each chamber 
and as such the 15 min switching period extracted a good 
level of lactate. It was deemed worthwhile to try and extract 
both lactate and glucose from the human subjects utilizing 
the 15 minute switching interval.
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Figure 5 Graphical comparison of real blood glucose levels of healthy subjects and glucose levels in the collection methylcellulose gel after reverse iontophoresis. 
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Figure 6 Graphical comparison of real blood lactate levels of healthy subjects and lactate levels in the collection methylcellulose gel after reverse iontophoresis.International Journal of Nanomedicine 2008:3(2) 221
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In the human studies, 40% of the subjects still displayed 
very mild erythema even when bipolar current was employed 
for reverse iontophoresis despite the polarity reversal of the 
electrodes.
Relatively few researchers have investigated glucose 
extraction by reverse iontophoresis in human subjects (see for 
example: Rao et al 1995; Potts et al 2002; Sieg et al 2004a, 
2004b) and no researchers have studied the effects of reverse 
iontophoresis on lactate extraction both in human subjects 
and in vitro. Rao and colleagues (1995) passed a direct cur-
rent (0.25 mA/cm2) across the human skin (ventral forearm) 
of subjects for a period of 60 minutes to extract glucose out 
of the skin and they found that around 5.83 nmol of glucose 
could be extracted at the cathode, somewhat less than found 
in this study. In the present study around 14 nmol of glucose 
was extracted by the application of bipolar direct current for 
60 minutes. The possible explanation might be that we used a 
slightly higher current density (0.3 mA/cm2) compared with 
the study by Rao and colleagues (1995) More importantly, we 
used a bipolar direct current rather than a direct current. Since 
glucose is mainly extracted out of the skin by electroosmosis 
and bipolar direct current can prevent the reduction in the 
level of electroosmosis, bipolar direct current can promote 
more glucose extraction than direct current.
In this study reverse iontophoresis signiﬁ  cantly promoted 
transdermal lactate extraction, around 2.5 times greater than 
diffusion alone, but there is no other human study for data 
comparison.
The concentration levels of glucose and lactate found in 
the gel electrodes had average values 150 µM for glucose 
and 330 µM for lactate. These concentration levels would 
be eminently suitable for biosensor detection directly in the 
gel electrodes allowing continuous monitoring of both.
In summary, both glucose and lactate can be effectively 
and noninvasively extracted from human subjects simultane-
ously by reverse iontophoresis. This illustrates the potential 
for the development of a continuous and noninvasive system 
to concurrently monitor blood glucose and lactate levels. To 
arrive at this a calibration of internal versus external glucose 
and lactate will be required for each individual subject. We 
have only been able to study this in a limited manner in the 
current work. As shown in Figures 5 and 6, there was a poor 
correlation across the subject group between blood glucose 
and extracted glucose levels and blood lactate and extracted 
lactate levels. However, this is to be expected because of the 
known skin to skin permeability variations between human 
subjects. This was overcome in the GlucoWatch® and a 
calibration was possible for each individual user. Each user 
was able to calibrate the device by utilising a single ﬁ  nger 
stick internal blood glucose sample which the device cor-
related with the reverse iontophoresis glucose level of the 
wearer at a single point in time (Tamada et al 1999). This 
was then used in an algorithm to link reverse iontophoresis 
glucose to internal glucose without the need for any further 
blood tests for a period of up to 12 hours. It is hoped that 
long term temporal studies on individual subjects will allow 
similar calibration procedures to be developed for lactate and 
glucose in simultaneous monitoring.
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